Total venture capital dollars invested in medical device companies jumped more than 20% during the 2nd quarter, but early-stage companies are still out in the cold.
Life science venture capital funding saw a major boost in the 2nd quarter as public markets smiled on biotech companies, but medical device makers saw a significant boost of their own – as long as they weren't early-stage firms.
A new report from PricewaterhouseCoopers finds lots of room for improvement in medical device makers' approach to the digital age, including in their use of social media, big data and mobile apps.
The healthcare space is getting a major influx of digital innovation, but much of it's coming from outside the traditional parameters of the industry.
Medtronic CEO Omar Ishrak douses himself with ice-water to raise awareness and money for research into amyotrophic lateral sclerosis.
The so-called Ice Bucket Challenge has reached the medtech sphere in a big way, with Medtronic (NYSE:MDT) CEO Omar Ishrak getting in on the viral video phenomenon with a short video showing him pouring a bucket of ice water over his head for charity.
The medical device industry posted modest job gains last year, and the industry is getting "purer" as more companies spin out their pharmaceutical divisions.
Last year may not have been a blockbuster one for medical device makers, but the industry posted steady gains in jobs, according to a new report from EP Vantage.
The analysis of nearly 100 small and large medtech companies found that jobs increased, on average, across the board. A closer look at the top 15 device makers found that jobs increased 6% overall and only 3 of the titans reduced their total headcount during the year, 2 of them by spinning out their pharma divisions.
MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.
MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
Leadership at Johnson & Johnson and Teleflex weigh in on the multi-billion-dollar mergers that are shifting the landscape of the medical device industry.
MASSDEVICE ON CALL — More medical device giants offered their 2¢ on high-dollar mega-mergers, joining other companies in saying that they aren't planning any billion-dollar buys just yet.
Medical device startups face significant headwinds in finding funding and getting to an exit, but at least prospective buyers are a little more willing to gamble on companies that haven't yet made it through the FDA.
The funding environment for medical device startups isn't a pretty scene, but there is a ray of sunshine through the gloom: lack of FDA approval is no longer a deal-breaker for a big exit.
In 2013 a few medtech companies managed "big exit M&A" deals (those worth $50 million or more) without having reached the FDA's brass ring, according to a new report from Silicon Valley Bank.